Viromed Medical AG (Q11) — Net Asset Quality Index
Viromed Medical AG (Q11) has a Net Asset Quality Index of 79.4% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €339.03 Million minus total liabilities of €69.84 Million yields net assets of €269.20 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Viromed Medical AG (Q11) asset resilience to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Viromed Medical AG Net Asset Quality Index Over Time (2021–2024)
This chart shows how Viromed Medical AG's Net Asset Quality Index has evolved across 4 annual periods from 2021 to 2024. As of September 2025, the index stands at 79.4%, representing net assets of €269.20 Million against total assets of €339.03 Million EUR. See working capital to net assets of Viromed Medical AG to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Viromed Medical AG (2021–2024)
The table below presents the year-by-year Net Asset Quality Index for Viromed Medical AG from 2021 to 2024, covering 4 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Viromed Medical AG market cap and net worth.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 78.6% | €201.16 Million | €255.98 Million | €54.82 Million | ▲ +18.6 pp |
| 2023 | 59.9% | €64.28 Million | €107.24 Million | €42.96 Million | ▼ -37.2 pp |
| 2022 | 97.1% | €63.23 Million | €65.10 Million | €1.87 Million | ▲ +3.7 pp |
| 2021 | 93.4% | €39.97 Million | €42.78 Million | €2.81 Million | — |